Summary
The global Peptide-Based Cancer Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Peptides are a combination of more than amino acids monomers attached by amino acids. It acts by binding to specific cell receptors and mimics like receptor ligands and helps in the treatment of various diseases such as cancer.
Increasing spending on the healthcare sector by the government around the globe is primarily fueling the market growth of the peptide based cancer therapeutics. According to the World Health Organization, global spending on the healthcare sector was US$ 7.8 trillion in 2017, or about 10% of GDP an increase from US$ 7.6 trillion in 2016. Advancement in treatment of the cancer treatment is again anticipated to bolster the market growth of peptide-based cancer therapeutics. For instance, in April 2020, GenScript, a biotechnology company, announced the commercial launch of its neoantigen peptide synthesis service for biotech and pharma companies developing personalized cancer therapeutics.
North America is expected to gain significant growth over the forecast period and this is attributed to increasing research and development activities by major players to develop cancer therapies. Genentech enters into partnership with Bicycle Therapeutics, for adding a new alliance in cancer research for the clinical-stage biotech. Under this agreement, Roche subsidiary Genentech has paid Bicycle $30 million upfront for developing a new class of drugs comprised of peptides, which are chains of amino acids.
Key Developments:
- In April 2020, Targovax ASA, a clinical-stage immuno-oncology company developing oncolytic viruses and cancer vaccines to target hard-to-treat solid tumors, and Valo Therapeutics (Valo Tx) announced that they have entered into a collaboration agreement to evaluate PeptiCRAd technology as a tool to coat ONCOS oncolytic adenoviruses with Targovax’s TG mutant RAS peptides.
- In July 2019, Boehringer Ingelheim announced its acquisition of all shares of AMAL Therapeutics SA, which focused on cancer immunotherapy and advancing first-in-class therapeutic cancer vaccines derived from its technology platform KISIMA.
- In November 2018, DNAtrix and Valo Therapeutics announced an R&D collaboration to develop improved vaccines using DNAtrix’s clinical-stage viruses and Valo’s proprietary antigenic peptide technology.
- In January 2020, Bicycle Therapeutics plc a biotechnology company of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, announced a second collaboration with Cancer Research UK, in which Cancer Research UK will fund and sponsor development of BT7401, a multivalent Bicycle CD137 agonist, through a Phase IIa clinical study.
The Peptide-Based Cancer Therapeutics Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Peptide-Based Cancer Therapeutics Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Pfizer
- AstraZeneca
- Johnson & Johnson
- Abbott Laboratories
- Allergan
- AbbVie
- Bausch Health
- Takeda Pharmaceutical
By the Product Type, the market is primarily segmented into:
- Goserelin
- Bortezomib
- leuprorelin
- Others
By Applications, the market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Peptide-Based Cancer Therapeutics Market Report:
- To assess the size of the market by value and volume
- Analyze the Peptide-Based Cancer Therapeutics Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Peptide-Based Cancer Therapeutics Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Peptide-Based Cancer Therapeutics Market
The Peptide-Based Cancer Therapeutics Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Peptide-Based Cancer Therapeutics Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
Peptide Based Cancer Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Peptide Based Cancer Therapeutics
1.1 Peptide Based Cancer Therapeutics Market Overview
1.1.1 Peptide Based Cancer Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Peptide Based Cancer Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Peptide Based Cancer Therapeutics Market by Type
1.3.1 Global Peptide Based Cancer Therapeutics Revenue (Million US$) and Growth Comparison by Type (2014-2025)
1.3.2 Global Peptide Based Cancer Therapeutics Revenue Market Share by Type in 2018
1.3.3 Goserelin
1.3.4 Bortezomib
1.3.5 leuprorelin
1.3.6 Others
1.4 Peptide Based Cancer Therapeutics Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global Peptide Based Cancer Therapeutics Competition Analysis by Players
2.1 Global Peptide Based Cancer Therapeutics Market Size (Million US$) by Players (2014-2019)
2.2 Competitive Status
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Mergers & Acquisitions, Expansion Plans
3 Company (Top Players) Profiles and Key Data
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 AstraZeneca
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Johnson & Johnson
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Abbott Laboratories
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Allergan
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 AbbVie
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Bausch Health
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Takeda Pharmaceutical
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Peptide Based Cancer Therapeutics Revenue (Value) (2014-2019)
3.8.5 Recent Developments
4 Global Peptide Based Cancer Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Peptide Based Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Peptide Based Cancer Therapeutics in Future
4.4 Top Consumer/End Users of Peptide Based Cancer Therapeutics
5 North America Peptide Based Cancer Therapeutics Development Status and Outlook
5.1 North America Peptide Based Cancer Therapeutics Market Size (2014-2019)
5.2 North America Peptide Based Cancer Therapeutics Market Size and Market Share by Players (2014-2019)
5.3 North America Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)
6 Europe Peptide Based Cancer Therapeutics Development Status and Outlook
6.1 Europe Peptide Based Cancer Therapeutics Market Size (2014-2019)
6.2 Europe Peptide Based Cancer Therapeutics Market Size and Market Share by Players (2014-2019)
6.3 Europe Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)
7 China Peptide Based Cancer Therapeutics Development Status and Outlook
7.1 China Peptide Based Cancer Therapeutics Market Size (2014-2019)
7.2 China Peptide Based Cancer Therapeutics Market Size and Market Share by Players (2014-2019)
7.3 China Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)
8 Rest of Asia Pacific Peptide Based Cancer Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size and Market Share by Players (2014-2019)
8.3 Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)
9 Central & South America Peptide Based Cancer Therapeutics Development Status and Outlook
9.1 Central & South America Peptide Based Cancer Therapeutics Market Size (2014-2019)
9.2 Central & South America Peptide Based Cancer Therapeutics Market Size and Market Share by Players (2014-2019)
9.3 Central & South America Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)
10 Middle East & Africa Peptide Based Cancer Therapeutics Development Status and Outlook
10.1 Middle East & Africa Peptide Based Cancer Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Peptide Based Cancer Therapeutics Market Size and Market Share by Players (2014-2019)
10.3 Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application (2014-2019)
11 Market Forecast by Regions and Application (2019-2025)
11.1 Global Peptide Based Cancer Therapeutics Market Size by Regions (2019-2025)
11.1.1 North America Peptide Based Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Peptide Based Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Peptide Based Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Peptide Based Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Peptide Based Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Peptide Based Cancer Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Peptide Based Cancer Therapeutics Market Size by Application (2019-2025)
11.3 The Market Drivers in Future
12 Peptide Based Cancer Therapeutics Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Table
List of Tables and Figures
Figure Global Peptide Based Cancer Therapeutics Market Size (Million USD) Status and Outlook (2014-2025)
Table Global Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2025)
Figure Global Peptide Based Cancer Therapeutics Market Share by Regions (2014-2019)
Figure North America Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Europe Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure China Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Central & South America Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Middle East & Africa Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Peptide Based Cancer Therapeutics Market Share by Type in 2018 & 2025
Figure Goserelin Market Size (Million USD) and Growth Rate (2014-2019)
Figure Bortezomib Market Size (Million USD) and Growth Rate (2014-2019)
Figure leuprorelin Market Size (Million USD) and Growth Rate (2014-2019)
Figure Others Market Size (Million USD) and Growth Rate (2014-2019)
Table Global Peptide Based Cancer Therapeutics Market Size (Million US$) Comparison by Application (2014-2025)
Figure Global Peptide Based Cancer Therapeutics Market Share by Application in 2018 & 2025
Figure Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2014-2019)
Figure Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate in Retail Pharmacies (2014-2019)
Figure Peptide Based Cancer Therapeutics Market Size (Million USD) and Growth Rate in Online Pharmacies (2014-2019)
Table Global Peptide Based Cancer Therapeutics Revenue (Million US$) by Players (2014-2019)
Table Global Peptide Based Cancer Therapeutics Revenue Market Share by Players (2014-2019)
Eigure Peptide Based Cancer Therapeutics Market Size Share by Players in 2018
Table Global Peptide Based Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Global Top 5 Players Peptide Based Cancer Therapeutics Market Share in 2018
Figure Global Top 10 Players Peptide Based Cancer Therapeutics Market Share in 2018
Table Peptide Based Cancer Therapeutics Key Players Product/Service
Table Mergers & Acquisitions, Expansion Plans
Table Pfizer Basic Information List
Table Pfizer Description and Business Overview
Table Pfizer Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of Pfizer (2014-2019)
Table Pfizer Peptide Based Cancer Therapeutics Recent Developments
Table AstraZeneca Basic Information List
Table AstraZeneca Description and Business Overview
Table AstraZeneca Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of AstraZeneca (2014-2019)
Table AstraZeneca Peptide Based Cancer Therapeutics Recent Developments
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of Johnson & Johnson (2014-2019)
Table Johnson & Johnson Peptide Based Cancer Therapeutics Recent Developments
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Description and Business Overview
Table Abbott Laboratories Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of Abbott Laboratories (2014-2019)
Table Abbott Laboratories Peptide Based Cancer Therapeutics Recent Developments
Table Allergan Basic Information List
Table Allergan Description and Business Overview
Table Allergan Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of Allergan (2014-2019)
Table Allergan Peptide Based Cancer Therapeutics Recent Developments
Table AbbVie Basic Information List
Table AbbVie Description and Business Overview
Table AbbVie Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of AbbVie (2014-2019)
Table AbbVie Peptide Based Cancer Therapeutics Recent Developments
Table Bausch Health Basic Information List
Table Bausch Health Description and Business Overview
Table Bausch Health Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of Bausch Health (2014-2019)
Table Bausch Health Peptide Based Cancer Therapeutics Recent Developments
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Description and Business Overview
Table Takeda Pharmaceutical Peptide Based Cancer Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Cancer Therapeutics Business of Takeda Pharmaceutical (2014-2019)
Table Takeda Pharmaceutical Peptide Based Cancer Therapeutics Recent Developments
Table Global Peptide Based Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Figure Global Peptide Based Cancer Therapeutics Revenue Market Share by Type in 2018
Table Global Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Global Peptide Based Cancer Therapeutics Revenue Market by Application in 2018
Table Top Consumer/End Users of Peptide Based Cancer Therapeutics
Figure North America Peptide Based Cancer Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table North America Peptide Based Cancer Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure North America Peptide Based Cancer Therapeutics Market Size Share by Players in 2018
Table North America Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure North America Peptide Based Cancer Therapeutics Revenue Market Share by Application (2014-2019)
Figure North America Peptide Based Cancer Therapeutics Market Size Share by Application in 2018
Figure Europe Peptide Based Cancer Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Europe Peptide Based Cancer Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Europe Peptide Based Cancer Therapeutics Market Size Share by Players in 2018
Table Europe Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Europe Peptide Based Cancer Therapeutics Revenue Market Share by Application (2014-2019)
Figure Europe Peptide Based Cancer Therapeutics Market Size Share by Application in 2018
Figure China Peptide Based Cancer Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table China Peptide Based Cancer Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure China Peptide Based Cancer Therapeutics Market Size Share by Players in 2018
Table China Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure China Peptide Based Cancer Therapeutics Revenue Market Share by Application (2014-2019)
Figure China Peptide Based Cancer Therapeutics Market Size Share by Application in 2018
Figure Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size Share by Players in 2018
Table Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Rest of Asia Pacific Peptide Based Cancer Therapeutics Revenue Market Share by Application (2014-2019)
Figure Rest of Asia Pacific Peptide Based Cancer Therapeutics Market Size Share by Application in 2018
Figure Central & South America Peptide Based Cancer Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Central & South America Peptide Based Cancer Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Central & South America Peptide Based Cancer Therapeutics Market Size Share by Players in 2018
Table Central & South America Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Central & South America Peptide Based Cancer Therapeutics Revenue Market Share by Application (2014-2019)
Figure Central & South America Peptide Based Cancer Therapeutics Market Size Share by Application in 2018
Figure Middle East & Africa Peptide Based Cancer Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Middle East & Africa Peptide Based Cancer Therapeutics Market Size Share by Players in 2018
Table Middle East & Africa Peptide Based Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Middle East & Africa Peptide Based Cancer Therapeutics Revenue Market Share by Application (2014-2019)
Figure Middle East & Africa Peptide Based Cancer Therapeutics Market Size Share by Application in 2018
Figure Global Peptide Based Cancer Therapeutics Market Size and Growth Rate (Value) (2019-2025) (Million US$)
Table Global Peptide Based Cancer Therapeutics Market Size by Regions (2019-2025) (Million US$)
Figure Global Peptide Based Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Peptide Based Cancer Therapeutics Market Size Share by Regions in 2025
Figure North America Peptide Based Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Peptide Based Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Peptide Based Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Peptide Based Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Peptide Based Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Peptide Based Cancer Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Peptide Based Cancer Therapeutics Market Size by Application (2019-2025) (Million USD)
Figure Global Peptide Based Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Peptide Based Cancer Therapeutics Market Size by Application in 2025
Table Global Peptide Based Cancer Therapeutics Market Size by Type (2019-2025) (Million US$)
Figure Global Peptide Based Cancer Therapeutics Market Size by Type (2019-2025)
Figure Global Peptide Based Cancer Therapeutics Market Size by Type in 2025
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Request Discount 
Inquire Before Buy
